Midwest Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Midwest Trust's NVO Position: Q2 2026 in Review
Midwest Trust sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 6,853 shares — an estimated $252K sold.
Midwest Trust first reported a position in NVO in Q2 2025 and held it in 4 quarters. The position peaked at $599K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Midwest Trust reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Midwest Trust sold 6,853 Novo Nordisk shares in Q2 2026, an estimated $252K.
- Midwest Trust first reported a position in Novo Nordisk in Q2 2025 and held it in 4 quarters.
- Midwest Trust's Novo Nordisk position peaked at $599K in Q2 2025.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.